An important Senate committee in New Mexico has unanimously advanced legislation to create a program for the medicinal use of ...

MOUNTAIN VIEW, Calif. - Alto Neuroscience, Inc. (NYSE: ANRO), currently trading at $3.11 and down nearly 26% over the past week, has announced the continuation of its Phase 2b clinical trial for ...

What to expect? Pariksha Pe Charcha 2025 will unfold in an new format spanning eight episodes. It will feature renowned ...

Biohaven's NDA for Troriluzole was accepted by the FDA, potentially leading to approval in Q3 2025. Click here to find out ...

Speaking in depth about her depression, Welch shared the tell-tale signs that occur in her body when a depressive episode is ...

Cybin pushes forward with Phase 3 depression trials after posting a narrower loss, while securing a $100M funding program.

BD affects millions but remains misunderstood, underdiagnosed, and underfunded. Researchers are working to change this by ...

Another sinkhole opened along a major New Jersey interstate Monday morning, forcing state officials to close the road’s eastbound lanes — just two months after another sinkhole shuttered it at nearly ...

Axsome settles Auvelity patent litigation with Teva, delaying a generic launch until 2038. Analysts see growth potential with Symbravo's migraine approval.

WHARTON, N.J. - Emergency sinkhole repairs on I-80 east in Wharton, New Jersey have had traffic backed up for hours Monday. "They got lucky nobody got hurt," said Chris Cota, of Blairstown. Cota said ...

With the settlement, Teva will not market the Auvelity generic until September 30, 2038, Axsome said in a Monday press ...

Self-care is important for everyone to prioritize mental, emotional and physical well-being. It includes doing something you ...